Cholesterol and lipoproteins: beyond atherogenesis (Q35633523)

9 August 2017

1 reference

title

Cholesterol and lipoproteins: beyond atherogenesis (English)

1 reference

9 August 2017

Kuhn FE

1

1 reference

9 August 2017

Mohler ER 3rd

series ordinal

2

1 reference

9 August 2017

Rackley CE

series ordinal

3

1 reference

9 August 2017

publication date

1 December 1992

1 reference

9 August 2017

1 reference

9 August 2017

volume

15

1 reference

9 August 2017

issue

12

1 reference

9 August 2017

page(s)

883-890

1 reference

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

Epidemiology of coronary heart disease: the Framingham study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Diet, serum cholesterol, and death from coronary heart disease. The Western Electric study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Dietary Prevention of Coronary Heart Disease: The Finnish Mental Hospital Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Coronary angioscopy in patients with unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effect of diet-induced hyperlipidemia on in vitro-function of rabbit platelets

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Hyperlipidemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Arterial platelet accumulation in experimental hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Platelet function and survival in rats with genetically determined hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Platelet function in hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Platelet interaction with high and low density lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Low density lipoprotein binding to human platelets: Role of charge and of specific amino acids

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Platelet hypersensitivity induced by cholesterol incorporation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effect of cholesterol on production of thromboxane b2 by platelets in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Clofibrate reversal of platelet hypersensitivity in hyperbetalipoproteinemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effects of clofibrate with androsterone (atromid) and without androsterone (atromid-S) on blood platelets and lipids in ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effects of clofibrate on platelets and evidence of the involvement of platelet lipids in platelet function

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

The anti-platelet effect of niceritrol in patients with arteriosclerosis and the relationship of the lipid-lowering effect to the anti-platelet effect.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Nicotinic acid inhibits thromboxane synthesis in platelets

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Haemostatic function and cardiovascular death: early results of a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Coagulation factors and the progress of coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Plasma factor VII is activated by postprandial triglyceridaemia, irrespective of dietary fat composition

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

A novel form of factor VII in plasma from men at risk for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Factor VII-phospholipid complex in male survivors of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

The fibrinolytic system and coagulation during bezafibrate treatment of hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effect of weight loss on coagulation factors VII and X

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

The triglyceride issue: a view from Framingham

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Lipoprotein(a), fibrin binding, and plasminogen activation.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Lipoprotein(a) inhibition of plasminogen activation by tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Studies on the protective effect of prostacyclin in acute myocardial ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

PGI2 Prevents Ischemia-Induced Alterations in Cardiac Catecholamines Without Influencing Nerve-Stimulation-Induced Catecholamine Release in Nonischemic Conditions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Protective actions of a stable prostacyclin analog in ischemia induced membrane damage in rat myocardium

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Prostacyclin infusion in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Influence of dietary fats on blood coagulation and prostaglandin production in the common marmoset

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Experimental atherosclerosis: effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Inhibition of prostaglandin I2 (PGI2) formation by LDL-cholesterol or LDL-peroxides?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Prostaglandin I2 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960151207

7 January 2021

Identifiers

DOI

10.1002/CLC.4960151207

1 reference

9 August 2017

1 reference